SC
GH icon

Stephens Consulting’s Guardant Health GH Stock Holding History

Stephens Consulting’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40
Closed -$1.7K – 1505
2025
Q1 		$1.7K Buy
+40
New +$1.73K ﹤0.01% 478
2022
Q1 		– Sell
-116
Closed -$11.6K – 624
2021
Q4 		$11.6K Buy
+116
New +$12K 0.01% 376

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Stephens Consulting's GH Position: Q2 2025 in Review

Stephens Consulting sold out of Guardant Health (GH) in Q2 2025, closing a stake of 40 shares — an estimated $1.7K sold.

Stephens Consulting first reported a position in GH in Q4 2021 and held it in 2 quarters. The position peaked at $11.6K in Q4 2021. 365 funds tracked by Wall St. Rank hold GH as of Q2 2025.

  • Stephens Consulting reported no remaining Guardant Health position as of Q2 2025 after selling out during the quarter.
  • Stephens Consulting sold 40 Guardant Health shares in Q2 2025, an estimated $1.7K.
  • Stephens Consulting first reported a position in Guardant Health in Q4 2021 and held it in 2 quarters.
  • Stephens Consulting's Guardant Health position peaked at $11.6K in Q4 2021.
  • 365 funds tracked by Wall St. Rank held Guardant Health as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.